Related references
Note: Only part of the references are listed.Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Bioinformatic and Genetic Association Analysis of MicroRNA Target Sites in One-Carbon Metabolism Genes
Nicole Stone et al.
PLOS ONE (2011)
Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma
Antal Csepregi et al.
BMC CANCER (2010)
Aberrant DNA methylation in contrast with mutations
Toshikazu Ushijima et al.
CANCER SCIENCE (2010)
Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry
Maria Berdasco et al.
DEVELOPMENTAL CELL (2010)
Molecular events in hepatic preneoplasia: A review
S. W. French
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
Mammalian microRNAs predominantly act to decrease target mRNA levels
Huili Guo et al.
NATURE (2010)
Accumulation of driver and passenger mutations during tumor progression
Ivana Bozic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies
James P. Hamilton
EPIGENOMICS (2010)
Quantitative Analysis of DNA Methylation Profiles in Lung Cancer Identifies Aberrant DNA Methylation of Specific Genes and Its Association with Gender and Cancer Risk Factors
Thomas Vaissiere et al.
CANCER RESEARCH (2009)
Genetic and Epigenetic Control of Molecular Alterations in Hepatocellular Carcinoma
Francesco Feo et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2009)
Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning
Rebecca A. Hinshelwood et al.
HUMAN MOLECULAR GENETICS (2009)
Global and gene-specific promoter methylation changes are related to anti-B[a]PDE-DNA adduct levels and influence micronuclei levels in polycyclic aromatic hydrocarbon-exposed individuals
Sofia Pavanello et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The N-terminus of histone H3 is required for de novo DNA methylation in chromatin
Jia-Lei Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation
Igor R. Pogribny et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Advances in chemical carcinogenesis: A historical review and prospective
Lawrence A. Loeb et al.
CANCER RESEARCH (2008)
Genetic and epigenetic changes in rat preneoplastic liver tissue induced by 2-acetylaminofluorene
Tetyana V. Bagnyukovay et al.
CARCINOGENESIS (2008)
Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: Studies in rodents
Igor P. Pogribny et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2008)
Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
Yutaka Kondo et al.
NATURE GENETICS (2008)
Combinatorial patterns of histone acetylations and methylations in the human genome
Zhibin Wang et al.
NATURE GENETICS (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Adenovirus small e1a alters global patterns of histone modification
Gregory A. Horwitz et al.
SCIENCE (2008)
Altered methionine metabolism and global DNA methylation in liver cancer: Relationship with genomic instability and prognosis
Diego F. Calvisi et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases
SunHwa Hong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Expression and clinical significance of methylenetetrahydrofolate reductase in patients with colorectal cancer
Elisabeth Odin et al.
CLINICAL COLORECTAL CANCER (2006)
Hypermethylation of NAD(P)H: quinone oxidoreductase 1 (NQO1) gene in human hepatocellular carcinoma
M Tada et al.
JOURNAL OF HEPATOLOGY (2005)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene
KE Bachman et al.
CANCER CELL (2003)
Role of histone H3 lysine 27 methylation in polycomb-group silencing
R Cao et al.
SCIENCE (2002)
DNA methylation and gene silencing in cancer: which is the guilty party?
SJ Clark et al.
ONCOGENE (2002)
Inhibition of liver methionine adenosyltransferase gene expression by 3-methylcolanthrene:: protective effect of S-adenosylmethionine
MV Carretero et al.
BIOCHEMICAL PHARMACOLOGY (2001)
SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity
H Yoshikawa et al.
NATURE GENETICS (2001)
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma
MA Avila et al.
JOURNAL OF HEPATOLOGY (2000)
Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma
N Iwata et al.
ONCOGENE (2000)
Dose response of early effects related to tumor promotion of 2-acetylaminofluorene
A Bitsch et al.
TOXICOLOGICAL SCIENCES (2000)
DNA methylation and histone acetylation of rat methionine adenosyltransferase 1A and 2A genes is tissue-specific
L Torres et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2000)
Share Paper
